Drug resistance rates of Mycobacterium tuberculosis strains in Austria between 1995 and 1998 and molecular typing of multidrug-resistant isolates

Epidemiology and Infection

Volumn 124, Issue 3, 2000, Pages 523-528

  Stauffer, F ^a   Makristathis, A ^b   Klein, J P ^c   Barousch, W ^b  

^a Federal Public Health Laboratory Austria   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Austrian Ministry of Labour   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; AUSTRIA; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS;

ADULT; AUSTRIA; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 0033869486     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899004021     Document Type: Article

References (21)

1. Tuberculosis notification update. Weekly Epidemiol Rec
2. The national coordinators for tuberculosis surveillance in 50 countries of the WHO European region. Surveillance of tuberculosis in the WHO European region, 1995-1996. Eurosurveillance
3. Tuberculosis control in Europe and international migration
4. The emergence of drug-resistant tuberculosis in New York
5. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey
6. Drug resistance of Mycobacterium tuberculosis in Korea
7. Multidrug-resistant tuberculosis
8. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
9. Tuberculosis in New York-turning the tide
10. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
11. Surveillance of tuberculosis in Europe. Recommendations of a working group of the World Health Organisation (WHO) and the European Region of the International Union Against Tuberculosis (IUATLD) for uniform cases
12. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens
13. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology
14. Detection of Mycobacterium tuberculosis complex in clinical specimens by a commercial polymerase chain reaction kit
15. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology
16. Infant tuberculosis in Austria-trend reversal since 1990
17. Investigation on the status of Mycobacterium tuberculosis resistance in Eastern Austria in 1992 and 1993
18. Nationwide surveillance of drug-resistant tuberculosis in the Netherlands: Rates, risk factors and treatment outcome
19. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 1997)